Clinical Trials Sponsored by Elon University

Total 219831 results

Elan Pharmaceuticals

Completed

Ziconotide Effectiveness and Safety Trial in Patients With Chronic Severe Pain

Pain

United States
Elan Pharmaceuticals

Terminated

A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

Multiple Sclerosis

United States, Canada
Elan Pharmaceuticals

Completed

A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache

Migraine Headache

United States
Elan Pharmaceuticals

Completed

Prialt (Ziconotide) In Severe Chronic Pain

Pain

United States
Elan Pharmaceuticals

Completed

Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.

Stroke | Multiple Sclerosis | Muscle Spasticity | Spinal Cord Injury

United States
Elan Pharmaceuticals

Terminated

Open-label Adjunctive Zonisamide for Bipolar Disorder

Bipolar Disorders
Elan Pharmaceuticals

Terminated

A Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

Multiple Sclerosis
Prof. Elon Pras

Unknown

A Controlled Study of Potential Therapeutic Effect of Oral Zinc in Manifesting Carriers of Wilson Disease

Wilson Disease
Stanford University
Elan Pharmaceuticals

Completed

"DOES MYOBLOC™ IMPROVE FUNCTIONAL HAND USE IN YOUNG CHILDREN WITH A HYPERTONIC UPPER EXTREMITY?"

Cerebral Palsy

United States
Centre Leon Berard

Recruiting

Study Comparing the Efficacy of Peripherally Inserted Central Catheter (PICC) Placement With the Addition of Cyanoacrylate Glue Versus PICC Placement Alone in Patients With Cancer. (PICCandGLUE)

Cancer

France
Centre Leon Berard

Recruiting

Gene Signatures Searching of Sensitivity/Resistance to Neoadjuvant Radiotherapy in Patients With Resectable STS (RADIOSARC)

Soft Tissue Sarcomas

France
Centre Leon Berard

Recruiting

Multiparametric Quantitative MRI and Response to Neoadjuvant Radiotherapy for Soft-tissue Sarcoma (SarQuantIRM)

Soft Tissue Sarcoma | Resectable Soft Tissue Sarcoma | Adult Soft Tissue Sarcoma

France
Centre Leon Berard

Recruiting

Lung Ultrasound Score After ENT Cancer Surgery (LUSENT)

Tracheostomy | Surgery | Cancer of Head and Neck | Postoperative Pulmonary Complication

France
Centre Leon Berard

Recruiting

Profiling Program of Advanced/Metastatic Pancreatic Cancer Patients

Metastatic Pancreatic Cancer | Advanced Pancreatic Cancer

France
Centre Leon Berard

Recruiting

Feasibility Study to Assess an Adapted Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Transplantation (EVAADE)

Myelodysplastic Syndromes | Severe Combined Immunodeficiency | Acute Leukemia | Haematological Malignancy | Hemoglobinopathy in Children | Bone Marrow Aplasia

France
Centre Leon Berard

Recruiting

A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined With Atezolizumab Versus Imatinib Resumption Alone in Patients With Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments (ATEZOGIST)

Metastatic Gastrointestinal Stromal Tumor | Unresectable Gastrointestinal Stromal Tumor (GIST) | Locally Advanced Gastrointestinal Stromal Tumor (GIST)

France
Centre Leon Berard

Recruiting

Profiling Program of Cancer Patients With Sequential Tumor and Liquid Biopsies (PLANET) (PLANET)

Glioblastoma | Advanced / Metastic Solid Tumors | Chronic Leukemia Lymphocytic

France
Centre Leon Berard

Recruiting

Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (Gist-Ten)

C-KIT Mutation | Metastatic Gastrointestinal Stromal Tumor (GIST) | Advanced Gastrointestinal Stromal Tumor (GIST)

France
Clinica Gema Leon

Recruiting

Radiofrequency Intervention in Post COVID-19 Patients

Covid19 | Neurological Injury | Musculoskeletal Injury | Respiratory Injury

Spain
Centre Leon Berard

Recruiting

Measurement of Implant Stability by Resonance Frequency Analysis in Patients Treated for an Upper Aero-digestive Tract Cancer (STABICAN)

Cancer

France
Centre Leon Berard

Recruiting

Interest of PET-PSMA Imaging Potentialised by Androgen Blockade in Localized Prostatic Adenocarcinoma (PREFAcE)

Prostate Adenocarcinoma

France
Centre Leon Berard

Recruiting

MEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma (COTESARC)

Sarcoma,Soft Tissue

France
Centre Leon Berard

Recruiting

A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors. (MegaMOST)

Malignant Solid Tumor

France
Centre Leon Berard

Recruiting

PATAKESS Protocol : Clinical and Biological Analysis of Exocrine Pancreatic Tumors (PATAKESS)

Exocrine Pancreatic Cancer

France
Centre Leon Berard

Recruiting

COLON-IM : Microbiota and Immune Infiltrate in Normal, Dysplastic and Neoplastic Colorectal Tissue

Colorectal Cancer

France
Centre Leon Berard

Recruiting

Study of the Efficacy of Lenvatinib Combined With Denosumab in the Treatment of Patients With Predominant Bone Metastatic Radioiodine Refractory Differentiated Thyroid Carcinomas (LENVOS)

Thyroid Cancer Metastatic

France
Centre Leon Berard

Recruiting

BIOREN (Predictive BIOmarkers in Metastatic RENal Cancer) (BIOREN)

Renal Cancer Metastatic

France
Centre Leon Berard

Recruiting

LIquid BIopsies in Patients Presenting Non-small Cell Lung Cancer (LIBIL)

Carcinoma, Non-Small-Cell Lung

France
Centre Leon Berard

Recruiting

Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer (PROFILER)

Neoplasms

France
Centre Leon Berard

Active, not recruiting

Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase (TIPI)

Philadelphia Chromosome Positive CML | BCR-ABL Positive Chronic Myelogenous Leukemia

France
Centre Leon Berard

Withdrawn

Impact of 5-Fluorouracil (5-FU) on Cancer Cells From Liver Metastases of Colon Cancer (FLUORIB)

Cancer of Colon | Metastasis to Liver

France
Centre Leon Berard

Active, not recruiting

Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA) (VICTORIA)

Endometrial Carcinoma | Hormone Receptor Positive Tumor | Metastatic Carcinoma

France
Centre Leon Berard

Completed

Lifestyle Intervention After Colonoscopy (LIFE-SCREEN Pilot)

Colorectal Cancer

France
Centre Leon Berard

Active, not recruiting

Evaluate the Clinical Benefit of a Post-operative Treatment Associating Radiotherapy + Nivolumab + Ipilimumab Versus Radiotherapy + Capecitabine for Triple Negative Breast Cancer Patients With Residual Disease (BreastImmune03)

Breast Cancer | Triple Negative Breast Neoplasms

France
Centre Leon Berard

Completed

Evaluation of the Feasibility and Clinical Relevance of Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer (LIBELULE)

Metastatic Lung Cancer

France
Centre Leon Berard

Completed

An Individualized Physical Activity Program in Patients Over 65 Years With Hematologic Malignancies (OCAPI)

Quality of Life | Lymphoma, Non-Hodgkin | Leukemia, Myeloid, Acute | Fatigue | Exercise | Aged | Aged, 80 and Over

France
Biogen
Elan Pharmaceuticals

Completed

Evaluation of Natalizumab for thE Relief of MS Associated FatiGue (ENER-G)

Multiple Sclerosis

United States, Puerto Rico
Centre Leon Berard

Completed

Assessment of the Reasons for Accepting or Refusing Early Palliative Care (PALPHA-1)

Cancer

France
Clinica Gema Leon

Completed

Craniosacral Therapy Children's, Balance-Coordination (CS-CHILDREN)

Healthy Children

Spain
Centre Leon Berard

Terminated

Study of the Efficacy of SBRT on Unresectable Peripheral Primary Tumor (GFPC_01-14)

Non-small-cell Lung Carcinoma

France
Centre Leon Berard

Unknown

Feasibility Study of 68Ga-PSMA PET-CT and 18F-FDOPA PET-CT in Glioblastoma's Patients (PAraDiGM)

Glioblastomas

France
Centre Leon Berard

Completed

Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 Infection (ONCOVID-19)

Cancer | Sars-CoV2

France
Centre Leon Berard

Unknown

Study of the Response to a Neoadjuvant Chemotherapy Based on the Antitumor Immune Response in Localized Breast Cancer (BREAST IMMUN)

Breast Cancer

France
Centre Leon Berard

Unknown

Immunomonitoring of Children With Neuroblastoma (Immuneuro)

Neuroblastoma

France
Biogen
Elan Pharmaceuticals

Completed

Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis

Multiple Sclerosis, Relapsing-Remitting

United Kingdom, United States, Canada, Belgium, Czech Republic, France, Germany, Netherlands
Centre Leon Berard

Completed

Xenon Combined With Intraoperative Thoracic Epidural Analgesia

Colorectal Cancer

France
Biogen
Elan Pharmaceuticals

Completed

Open Label Natalizumab Safety Extension Study for Subjects With Crohn's Disease

Crohn's Disease

United States
Biogen
Elan Pharmaceuticals

Completed

Safety, Tolerability and Effectiveness of Natalizumab in Adolescents With Active Crohn's Disease

Crohn's Disease

United States, United Kingdom
Biogen
Elan Pharmaceuticals

Terminated

A Phase II, Multicenter, Open-Label, Long-Term Study of the Safety, Tolerability, and Efficacy of Intravenous Natalizumab in Subjects With Rheumatoid Arthritis Who Have Previously Participated in Study ELN100226-RA201

Rheumatoid Arthritis
Biogen
Elan Pharmaceuticals

Completed

Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease

Crohn's Disease

United States

3

Subscribe